Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DRVN | BRVE |
|---|---|---|
| Price | $11.65 | $21.35 |
| Change today | ▼ 0.26% | ▲ 0.38% |
| Market cap | $1.92B | $1.92B |
| Return, 3 months | -23.0% | – |
| Return, year to date | -21.4% | – |
| Return, 1 year | -24.0% | – |
| P/E (TTM) | 11.7 | -3.5 |
| P/B | 2.3 | -20.0 |
| P/E percentile vs own 5y | 63rd | 81st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | -3,833.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +24.5% | +111.9% |
| Analyst buy share | 22% | 100% |
| RSI (14) | 38 | 39 |
| 30-day volatility | 35.8% | 93.2% |
| Max drawdown, 1 year | -39.7% | -32.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
